Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EVE Health Group Limited ( (AU:EVE) ) has provided an announcement.
EVE Health Group Limited has released a transaction-specific prospectus outlining a capital raising via a placement of 64.7 million shares at $0.02 each, seeking $1.294 million, alongside associated options for placement subscribers and directors. The company will also issue options to the lead manager and shares to a corporate adviser for no cash consideration, with several components of the offer subject to shareholder approval and ASX quotation applications to be lodged within seven days of the prospectus date.
The prospectus, lodged with ASIC on 20 March 2026, covers offers of continuously quoted securities and options under section 713 of the Corporations Act, providing a lower level of disclosure than an IPO document. Distribution of the offer is restricted to investors in Australia and New Zealand, with a Target Market Determination available on the company’s website to guide suitability for potential option investors based on their objectives and financial circumstances.
The most recent analyst rating on (AU:EVE) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on EVE Health Group Limited stock, see the AU:EVE Stock Forecast page.
More about EVE Health Group Limited
EVE Health Group Limited is an ASX-listed company in the health sector. It issues continuously quoted securities and operates under the Australian Corporations Act disclosure regime, targeting investors familiar with listed-company investment risks and regulatory requirements.
Average Trading Volume: 270,743
Technical Sentiment Signal: Sell
Current Market Cap: A$5.7M
For a thorough assessment of EVE stock, go to TipRanks’ Stock Analysis page.